{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:51:06Z","timestamp":1790970666915,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.nbd.2006.07.020","type":"journal-article","created":{"date-parts":[[2006,10,21]],"date-time":"2006-10-21T11:11:23Z","timestamp":1161429083000},"page":"35-44","source":"Crossref","is-referenced-by-count":110,"title":["Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism"],"prefix":"10.1016","volume":"25","author":[{"given":"Yotam","family":"Sagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Amit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moussa B.H.","family":"Youdim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2006.07.020_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ar.1090940210","article-title":"Estimation of muclear population from microtome sections","author":"Abercrombie","year":"1946","journal-title":"Anat."},{"key":"10.1016\/j.nbd.2006.07.020_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neulet.2003.10.067","article-title":"Contrasting neuroprotective and neurotoxic actions of respective metabolites of anti-Parkinson drugs rasagiline and selegiline","volume":"355","author":"Am","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2006.07.020_bib3","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1096\/fj.05-3794fje","article-title":"Regulation of Bcl-2 family proteins, neurotrophic factors, and APP processing in the neurorescue activity of propargylamine","volume":"19","author":"Bar-Am","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2006.07.020_bib4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1527-3458.2005.tb00269.x","article-title":"Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease?","volume":"11","author":"Blandini","year":"2005","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.nbd.2006.07.020_bib5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.expneurol.2004.03.005","article-title":"Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease","volume":"187","author":"Blandini","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2006.07.020_bib6","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1242\/jcs.01505","article-title":"GSK-3beta inhibition\/beta-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons","volume":"117","author":"Castelo-Branco","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.nbd.2006.07.020_bib7","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1124\/mol.105.018671","article-title":"Implication of the phosphatidylinositol-3 kinase\/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice","volume":"69","author":"D'Astous","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2006.07.020_bib8","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1097\/00001756-199807130-00039","article-title":"GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged parkinsonian mice","volume":"9","author":"Date","year":"1998","journal-title":"NeuroReport"},{"key":"10.1016\/j.nbd.2006.07.020_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/gb-2003-4-5-p3","article-title":"DAVID: database for annotation, visualization, and integrated discovery","volume":"4","author":"DennisJr","year":"2003","journal-title":"Genome Biol."},{"key":"10.1016\/j.nbd.2006.07.020_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0378-4274(02)00428-9","article-title":"Apoptotic mechanisms and antiapoptotic therapy in the MPTP model of Parkinson's disease","volume":"139","author":"Eberhardt","year":"2003","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.nbd.2006.07.020_bib11","doi-asserted-by":"crossref","first-page":"34922","DOI":"10.1074\/jbc.M312697200","article-title":"Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity","volume":"279","author":"Elad-Sfadia","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2006.07.020_bib12","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1126\/science.1060645","article-title":"Dendrodendritic inhibition through reversal of dopamine transport","volume":"293","author":"Falkenburger","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.nbd.2006.07.020_bib13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/380252a0","article-title":"Functional recovery in parkinsonian monkeys treated with GDNF","volume":"380","author":"Gash","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2006.07.020_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2001.00397.x","article-title":"Gene expression analysis in MPTP mice model of Parkinson's disease using cDNA microarray","volume":"78","author":"Grunblatt","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2006.07.020_bib15","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1523\/JNEUROSCI.4564-03.2004","article-title":"Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease","volume":"24","author":"Hayley","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2006.07.020_bib16","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/311467a0","article-title":"Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors","volume":"311","author":"Heikkila","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2006.07.020_bib17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(85)90168-2","article-title":"Prevention of MPTP-induced neurotoxicity by AGN-1133 and AGN-1135, selective inhibitors of monoamine oxidase-B","volume":"116","author":"Heikkila","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2006.07.020_bib18","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1038\/sj.onc.1208527","article-title":"Modulation of specific protein expression levels by PTEN: identification of AKAP121, DHFR, G3BP, Rap1, and RCC1 as potential targets of PTEN","volume":"24","author":"Huang","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.nbd.2006.07.020_bib19","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.4049\/jimmunol.175.6.3790","article-title":"NF-kappaB couples protein kinase B\/Akt signaling to distinct survival pathways and the regulation of lymphocyte homeostasis in vivo","volume":"175","author":"Jones","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2006.07.020_bib20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1006\/bbrc.1997.7183","article-title":"Adenovirus-mediated transduction with human glial cell line-derived neurotrophic factor gene prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopamine depletion in striatum of mouse brain","volume":"238","author":"Kojima","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2006.07.020_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0006-8993(97)01495-9","article-title":"Topographical distribution of [125I]-glial cell line-derived neurotrophic factor in unlesioned and MPTP-lesioned rhesus monkey brain following a bolus intraventricular injection","volume":"789","author":"Lapchak","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2006.07.020_bib22","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1046\/j.1471-4159.2001.00490.x","article-title":"Green tea polyphenol (\u2212)-Epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration","volume":"78","author":"Levites","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2006.07.020_bib23","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/j.1471-4159.2005.03474.x","article-title":"The inhibition of glycogen synthase kinase 3beta by a metabotropic glutamate receptor 5 mediated pathway confers neuroprotection to Abeta peptides","volume":"95","author":"Liu","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2006.07.020_bib24","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm0705-703","article-title":"Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain","volume":"11","author":"Love","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2006.07.020_bib25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.neuint.2003.08.005","article-title":"N-Propargyl-1(R)-aminoindan, rasagiline, increases glial cell line-derived neurotrophic factor (GDNF) in neuroblastoma SH-SY5Y cells through activation of NF-kappaB transcription factor","volume":"44","author":"Maruyama","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2006.07.020_bib26","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.tips.2004.07.006","article-title":"Pharmacological inhibitors of glycogen synthase kinase 3","volume":"25","author":"Meijer","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2006.07.020_bib27","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/PL00000919","article-title":"Neurotrophin signalling pathways regulating neuronal apoptosis","volume":"58","author":"Miller","year":"2001","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.nbd.2006.07.020_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3940(98)00427-3","article-title":"Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to mice on interleukin-1beta and nerve growth factor in the striatum","volume":"250","author":"Mogi","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2006.07.020_bib29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(99)00463-2","article-title":"Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease","volume":"270","author":"Mogi","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2006.07.020_bib30","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/jnnp.64.3.314","article-title":"Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET","volume":"64","author":"Morrish","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2006.07.020_bib31","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archneur.61.4.561","article-title":"A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease","volume":"61","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2006.07.020_bib32","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0140-6736(05)71083-7","article-title":"Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial","volume":"365","author":"Rascol","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2006.07.020_bib33","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1212\/01.WNL.0000058760.13152.1A","article-title":"Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment","volume":"60","author":"Ravina","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2006.07.020_bib34","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1046\/j.1471-4159.2003.01801.x","article-title":"Attenuation of MPTP-induced dopaminergic neurotoxicity by TV3326. A cholinesterase-monoamine oxidase inhibitor","volume":"2","author":"Sagi","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2006.07.020_bib35","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1046\/j.1471-4159.2000.0751200.x","article-title":"MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo","volume":"75","author":"Saporito","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2006.07.020_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0014-2999(96)00593-6","article-title":"Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage","volume":"315","author":"Semkova","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2006.07.020_bib37","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/1097-4547(20010301)63:5<402::AID-JNR1035>3.0.CO;2-F","article-title":"Nerve growth factor prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced cell death via the Akt pathway by suppressing caspase-3-like activity using PC12 cells: relevance to therapeutical application for Parkinson's disease","volume":"63","author":"Shimoke","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2006.07.020_bib38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/bies.10378","article-title":"Neuroprotection by monoamine oxidase B inhibitors: a therapeutic strategy for Parkinson's disease?","volume":"26","author":"Tabakman","year":"2004","journal-title":"BioEssays"},{"key":"10.1016\/j.nbd.2006.07.020_bib39","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1124\/jpet.301.2.753","article-title":"Propargylamines induce antiapoptotic new protein synthesis in serum- and nerve growth factor (NGF)-withdrawn. NGF-differentiated PC-12 cells","volume":"301","author":"Tatton","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2006.07.020_bib40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/373335a0","article-title":"Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo","volume":"373","author":"Tomac","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2006.07.020_bib41","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1083\/jcb.146.5.955","article-title":"Depolarization and neurotrophins converge on the phosphatidylinositol 3-kinase-Akt pathway to synergistically regulate neuronal survival","volume":"146","author":"Vaillant","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2006.07.020_bib42","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.gt.3301682","article-title":"Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease","volume":"9","author":"Wang","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.nbd.2006.07.020_bib43","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1128\/MCB.22.3.916-926.2001","article-title":"The RAS effector RIN1 directly competes with RAF and is regulated by 14-3-3 proteins","volume":"22","author":"Wang","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2006.07.020_bib44","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1096\/fj.04-1916fje","article-title":"Neuroprotection via pro-survival protein kinase C isoforms associated with Bcl-2 family members","volume":"18","author":"Weinreb","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2006.07.020_bib45","doi-asserted-by":"crossref","first-page":"16439","DOI":"10.1074\/jbc.271.28.16439","article-title":"A role for the ral guanine nucleotide dissociation stimulator in mediating ras-induced transformation","volume":"271","author":"White","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2006.07.020_bib46","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2165\/00023210-200519090-00001","article-title":"Treatment of Parkinson's disease: what's on the horizon?","volume":"19","author":"Wu","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.nbd.2006.07.020_bib47","doi-asserted-by":"crossref","first-page":"24052","DOI":"10.1074\/jbc.273.37.24052","article-title":"Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase","volume":"273","author":"Yan","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2006.07.020_bib48","doi-asserted-by":"crossref","first-page":"31530","DOI":"10.1074\/jbc.M503120200","article-title":"Interferon induces NF-kappa B-inducing kinase\/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival","volume":"280","author":"Yang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2006.07.020_bib49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00702-005-0299-z","article-title":"N-Propargylamine protects SH-SY5Y cells from apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, through stabilization of mitochondrial membrane and induction of anti-apoptotic Bcl-2","volume":"113","author":"Yi","year":"2005","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2006.07.020_bib50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00702-005-0299-z","article-title":"N-Propargylamine protects SH-SY5Y cells from apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, through stabilization of mitochondrial membrane and induction of anti-apoptotic Bcl-2","volume":"113","author":"Yi","year":"2006","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.nbd.2006.07.020_bib51","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/sj.bjp.0703826","article-title":"Rasagiline [N-Propargyl-1R(+)-aminoindant], a selective and potent inhibitor of mitochondrial monoamine oxidase B","volume":"132","author":"Youdim","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2006.07.020_bib52","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/jnr.20350","article-title":"Rasagiline: neurodegeneration, neuroprotection, and mitochondrial permeability transition","volume":"79","author":"Youdim","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2006.07.020_bib53","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.neuroscience.2003.10.037","article-title":"Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase\/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways","volume":"123","author":"Zhu","year":"2004","journal-title":"Neuroscience"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996106002063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996106002063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T19:26:18Z","timestamp":1707333978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996106002063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0969996106002063"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2006.07.020","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}